Conformis Announces License Agreement with Paragon 28
19 avr. 2021 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a...
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
07 avr. 2021 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the...
Conformis, Inc. and SITES Medical Announce Development & Supply Agreement
21 janv. 2021 16h15 HE
|
Conformis, Inc.
BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical...
Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Conference
24 nov. 2020 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...
Conformis Reports Preliminary Third Quarter Revenue Results
06 oct. 2020 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third quarter ended September 30, 2020. Expected...
Conformis Announces 510(k) Clearance for Cordera™ Hip System
29 sept. 2020 10h45 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s new Cordera™ Hip...
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
24 sept. 2020 07h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to...
Conformis Announces Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund
18 déc. 2018 14h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,...
Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants
16 oct. 2017 08h00 HE
|
ConforMIS, Inc
BILLERICA, Mass., Oct. 16, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient's unique...
ConforMIS to Host Third Quarter 2017 Financial Results Conference Call and Webcast on November 1, 2017
12 oct. 2017 16h05 HE
|
ConforMIS, Inc
BILLERICA, Mass., Oct. 12, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ:CFMS) announced today that it will host a conference call on Wednesday, November 1, 2017, at 4:30 p.m. Eastern Time to...